The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines - either with in-house capabilities or together with partners - and evolve Idorsia into a leading biopharmaceutical company, with a strong scientific core.
Headquartered near Basel, Switzerland - a European biotech hub - Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ(TM) (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients. Idorsia is listed on the SIX Swiss Exchange (ticker symbol: IDIA).
The Business Analyst - Veeva R&D partners with Clinical, Regulatory, and Quality business functions to translate their requirements into compliant, effective, and user-friendly Veeva Vault solutions. The role ensures Veeva applications (Vault Clinical, Regulatory and Quality Suites) enable efficient processes, high-quality data, and global regulatory compliance.
Additionally, the Business Analyst provides dedicated end-user support by assisting users with application-related queries, troubleshooting issues, delivering training, and promoting optimal use of the Veeva Vault systems to enhance user experience and adoption.
MNCJobs.ch will not be responsible for any payment made to a third-party. All Terms of Use are applicable.